Overview

Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly

Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy, safety and tolerability of the octreotide implant in patients with acromegaly that were previously treated with octreotide depot.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Octreotide
Somatostatin